PRICE T ROWE ASSOCIATES INC /MD/
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,150,522
+$1,673,975 QoQ
Shares Held
773,446
+3.3% QoQ
Ownership
0.632%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. CPRX ranks #85 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in CPRX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,150,522 | 773,446 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,476,547 | 748,781 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,650,397 | 743,675 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,964,646 | 735,698 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,707,357 | 977,623 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,366,190 | 1,215,438 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,539,533 | 1,234,383 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,096,877 | 1,232,852 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $19,437,521 | 1,219,418 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,114,139 | 1,196,558 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $13,772,783 | 1,178,168 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,802,681 | 1,101,390 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,072,077 | 1,029,679 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,684,396 | 950,774 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $198,326 | 15,458 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||